SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018869
Filing Date
2019-05-13
Accepted
2019-05-13 16:48:31
Documents
64
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sldb-10q_20190331.htm 10-Q 2100076
2 EX-10.1 sldb-ex101_64.htm EX-10.1 33572
3 EX-31.1 sldb-ex311_8.htm EX-31.1 16301
4 EX-31.2 sldb-ex312_7.htm EX-31.2 15906
5 EX-32.1 sldb-ex321_6.htm EX-32.1 7740
6 EX-32.2 sldb-ex322_10.htm EX-32.2 7794
  Complete submission text file 0001564590-19-018869.txt   5802304

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT sldb-20190331.xml EX-101.INS 1097213
8 XBRL TAXONOMY EXTENSION SCHEMA sldb-20190331.xsd EX-101.SCH 39489
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sldb-20190331_cal.xml EX-101.CAL 47790
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sldb-20190331_def.xml EX-101.DEF 92645
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sldb-20190331_lab.xml EX-101.LAB 288409
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sldb-20190331_pre.xml EX-101.PRE 211060
Mailing Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139 617-337-4682
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

IRS No.: 900943402 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38360 | Film No.: 19819031
SIC: 2836 Biological Products, (No Diagnostic Substances)